|
|
Volumn 36, Issue 2, 2009, Pages 462-
|
|
Disseminated cryptococcal infection and anti-tumor necrosis factor-α treatment for refractory sarcoidosis: An expected association?
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN;
CLARITHROMYCIN;
CYCLOPHOSPHAMIDE;
ETANERCEPT;
FLUCONAZOLE;
FLUCYTOSINE;
INFLIXIMAB;
METHOTREXATE;
PREDNISONE;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ANTIFUNGAL AGENT;
ANTIRHEUMATIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
BACTERIUM CULTURE;
CASE REPORT;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL EXAMINATION;
COMPUTER ASSISTED TOMOGRAPHY;
COUGHING;
CRYPTOCOCCOSIS;
DISEASE ASSOCIATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
EYE EXAMINATION;
FEVER;
FUNGUS CULTURE;
HEADACHE;
HEARING IMPAIRMENT;
HISTOPATHOLOGY;
HUMAN;
LETTER;
LUNG BIOPSY;
LUNG LAVAGE;
MALE;
MENINGITIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PAPILLEDEMA;
PRIORITY JOURNAL;
SARCOIDOSIS;
SCINTIGRAPHY;
SEROLOGY;
THORAX RADIOGRAPHY;
TUBERCULIN TEST;
CHEMICALLY INDUCED DISORDER;
CRYPTOCOCCUS NEOFORMANS;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
HEART;
HEART DISEASE;
HEART MUSCLE;
HEART SCINTISCANNING;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
METABOLISM;
MICROBIOLOGY;
PATHOLOGY;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIFUNGAL AGENTS;
ANTIRHEUMATIC AGENTS;
CRYPTOCOCCOSIS;
CRYPTOCOCCUS NEOFORMANS;
DRUG THERAPY, COMBINATION;
HEART;
HEART DISEASES;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MYOCARDIAL PERFUSION IMAGING;
MYOCARDIUM;
SARCOIDOSIS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 64849088695
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: 10.3899/jrheum.080426 Document Type: Letter |
|
Times cited : (12)
|
|
References (9)
|
